Sublingual immunotherapy for allergy-related asthma
Immunotherapy using sublingual tablets containing house dust mite allergen extended the interval until patients developed a moderate asthma exacerbation in a manufacturer-sponsored clinical trial...
Source: Family Practice News - Category: Primary Care Source Type: news
More News: Allergy | Allergy & Immunology | Asthma | Clinical Trials | Family Practices | Immunotherapy | Primary Care